Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
178,179,180 In 2004, the FDA approved the first aptamer drug, pegaptanib (Macugen), to treat choroidal neovascularization caused by neovascular age-related macular degeneration (AMD)
Please note: Ingredient nomenclature may be updated to reflect exact supplier INCI documentation
According to estimates from MedPAC, negotiated rebates for diabetic therapy were equal to or greater than 50% in 2023
The product was applied twice daily, morning and evening, on the face, dcollet, and neck for 56 days.
US$ 22.06
US$ 27.12
US$ 26.01
US$ 21.31
US$ 28.72
US$ 26.67
US$ 26.84
US$ 24.86
